Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5783_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
40 Мб
Скачать
11 Neurocritical Patient in ICU: Transcranial Doppler (TCD/TCCS) as the Brain…
203
11.3.4 Autoregulation
Cerebral blood ow autoregulation refers to the intrinsic ability of the brain to maintain a stable cerebral blood ow (CBF) despite uctuations in cerebral perfu­sion pressure [35]. In many neurological diseases (including TBI, stroke), an impair­ment of this autoregulatory response has been demonstrated [36, 37] and seems that the degree of impairment is related to poor outcome.
Traditionally, assessment of cerebral autoregulation has been performed under steady-state conditions, at constant baselines ABP and CBF, and then another steady-state measurement was performed following manipulation of ABP.Many authors adopted TCD as a static model for autoregulation assessment in patients using the static autoregulatory index or static rate of regulation, dened as the net change in cerebral blood ow following the manipulation of cerebral perfusion pressure under steady state [38, 39].
Although for decades this classic static approach has been widely applied in clinical practice, it does not take into account different factors including the differ­ent upper and lower limits of autoregulation or different slopes of the “autoregula­tory zone” among different individuals [40]. Thus, the investigation of dynamic cerebral autoregulation using TCD is an area of signicant research given the high temporal resolution, which allows to measure the timing and the magnitude of the changes of CBF to the CPP/ABP challenge. This “dynamic” approach uses the induced or spontaneous rapid changes in ABP as an autoregulatory stimulus and compares ABP and CBFV during the whole autoregulatory process (dynamic pres­sure autoregulation) [41].
In brain monitoring, TCD/TCCS can be useful to calculate an index of autoregu­lation called mean ow index (Mx) which is the correlation coefcient index between MFV and CPP [42]. Zero or negative correlation indicates preserved auto­regulation, whereas a positive correlation between CPP and CBFV indicates impaired autoregulation. Mx index has shown to be strongly associated with poor outcome at 6 months in patients with impaired autoregulation after severe head injury [57]. More recently, Budohoski etal. [43] demonstrated in a cohort of 300 head-injured patients that a new autoregulation index, the Sx index (correlation between PSV and CPP), shows a stronger association with the patient outcome than Mx.
Despite the wide and generally accepted value of TCD in the assessment of cere­bral autoregulation, this technique has some limitations. Measurements of CBFV are frequently only taken from the MCA, and thus autoregulatory changes in the posterior circulation may not be detected [44]. Moreover, TCD-based studies use CBFV as a surrogate measure of CBF.However, CBFV is only proportional to CBF when vessel cross-sectional area remains constant, as previously mentioned.
204
nICP ABPnCPP= –.
C. Robba and D. Cardim
11.3.5 Non-invasive ICP andCPP
ICP evaluation and management is crucial in many neurological diseases, and it is commonly measured through intraventricular or intraparenchymal catheters which are accurate, but their invasive nature and related complications preclude their use in many conditions such as coagulopathy [45, 46]. TCD/TCCS waveform analysis has been widely investigated as a technique for nICP estimation.
TCD-derived nICP methods are based on the relationship between ICP and indi­ces derived from cerebral blood ow velocity. The correlation between PI and ICP has been extensively studied. However, reports on its usefulness for predicting ICP and CPP are discordant [47, 48]. Bellner etal. [25] found a signicant correlation (R=0.94, P<0.0001) between invasively measured ICP and PI, with good sensitiv­ity and specicity to detect ICP > 20 mmHg. Other authors found less positive results; Zweifel et al. [26] in a cohort of 290 patients found a weak correlation between PI and ICP (0.31; P<0.001), with a 95% prediction interval of ICP values wider than ±15mmHg. In a recent study, Cardim etal. [12] demonstrated a non­signicant correlation between nICP derived from PI and ICP measured invasively.
The role of PI in the assessment of ICP is not clear, and the variability of these results can be explained by the fact that increase in PI is not specic to increase in ICP.PI can increase following a decrease in CPP and ABP, or during decrease in partial pressure of CO
Many authors have proposed mathematical models that simulate the cerebrovas­cular dynamics using simultaneous CBFV and ABP measurements. In a Black-Box model for estimation of ICP, the intracranial compartment is considered a black-box system, with ICP being a system response (output signal ICP) to the incoming sig­nal ABP (input signal). Cardim etal. [12] evaluated the black-box method in a cohort of 40 TBI patients, obtaining a moderate correlation with measured ICP (R=0.39, P<0.05). Other mathematical models have also been proposed, such as the cerebrovascular dynamics model for non-invasive estimation of ICP according to Heldt [49].
Many authors have also studied and proposed methods based on the primarily intended calculation of non-invasive cerebral perfusion pressure (nCPP), and sec­ondarily calculating non-invasive ICP based on the assumption that (Eq.11.5)
or increase in pulsatility of ABP waveform [5].
2
Aaslid etal. [50] rst developed a mathematical model for non-invasive estima­tion of CPP based on transcranial Doppler waveform analysis based on spectral pulsatility index and the rst harmonic component of the arterial blood pressure, but this method demonstrated low accuracy.
Czosnyka etal. [51] proposed a similar but modied formula, based on the wave­form analysis of CBFV, which uses the EDV for the estimation of nCPP. In 96 patients suffering from head injury, the correlation between nCPP and measured CPP was R=0.73 (P<0.001), with estimation error less than 15mmHg and in 84% of the examinations.
(11.5)
11 Neurocritical Patient in ICU: Transcranial Doppler (TCD/TCCS) as the Brain…
Varsos etal. used a method based on CrCP [52]. According to this method, nCPP seems to be correlated with measured CPP (R=0.85, P<0.001), with a mean±SD difference of 4.02±6.01mmHg, and 83.3% of the cases with an estimation error below 10mmHg [52].
Considering the distinct categories for nICP estimation, there has been a consid­erable variability in the reported accuracy of these methods, and various methods demonstrated wide condence intervals for prediction and remain to be fully vali­dated [53]. Nevertheless, it is known that even the standard invasive techniques might not comply with the specied limits for error [5456]. Thus, it is debatable whether these accuracy requirements are realistic for all sorts of ICP monitoring.
In view of this, an important concept that should be stressed is ICP not solely “as a number,” once dynamical features of this parameter, such as its waveform and relative changes in time, are fundamental for a proper assessment of the clinical state of the patient [57]. Therefore, despite the intrinsic limitations and inaccuracy to predict ICP mean absolute values, TCD-based nICP methods may have a poten­tial clinical utility since this technique allows a non-invasive assessment of cerebral circulation dynamics as ICP changes over the time domain.
These features also allow tracking nICP changes in real time in a variety of clini­cal settings (emergency rooms, ambulatories, operating theaters). This is one of the advantages of transcranial Doppler ultrasonography and may become particularly useful as a primary assessment tool in centers where ICP monitoring is not routinely applied or unavailable. It may also suit patients in whom invasive ICP monitoring may not be clearly indicated (mild closed head injury, for example) or contraindi­cated (coagulopathy, for instance).
205
11.4 Applications ofTCD/TCCS Monitoring
inClinical Practice
11.4.1 Traumatic Brain Injury
Traumatic brain injury (TBI) is a relevant cause of morbidity and mortality, and several important disturbances of cerebral hemodynamics occur after TBI, includ­ing hyperemia, cerebral ischemia, and vasospasm.
Monitoring and targeted management of ICP and CPP are necessary for patients with severe traumatic brain injury. Intracranial hypertension and low CPP are asso­ciated with poor outcome, and the literature is clear about the importance of a strict neuromonitoring in order to avoid secondary brain insults [58].
TCD has been widely applied in TBI patients, in particular, for the assessment of ICP and CPP in human and animal studies [12]; moreover, some authors showed that impaired autoregulation, determined by TCD methods (Mx or Sx index), is strongly associated with poor outcome at 6months [42, 43]. TCD demonstrated to be useful in TBI patients as it is able to avoid the use of invasive techniques for the measurement of CBF and provide similar prognostic information [43].
206
C. Robba and D. Cardim
TCD can be also useful in TBI patients for the assessment of cerebral dynamics and cerebral swelling through the calculation of cerebral compliance. Hyperemia may occur a few hours after TBI, lasting 2 to 4days, and also be assessed using TCD patterns suggestive of high vascular resistance, consistent with elevated intra­cranial pressure [59], or following an ischemic event.
EDV and PI have been shown to have a role in the decision between “fast track” and standard ICP monitoring at admission in patients with TBI [60]. In the emer­gency room, TCD might complement brain computed tomography scan and clinical examination to screen patients at risk of further neurological deterioration after TBI.In a recent study [61], transcranial Doppler parameters showed a strong nega­tive predictive value (NPV) in TBI patients who did not undergo secondary neuro­logic deterioration, and patients with abnormal TCD patterns had greater disability 4weeks after TBI.
11.4.2 Aneurysmal Subarachnoid Hemorrhage
Aneurysmal subarachnoid hemorrhage (aSAH) has an incidence of 6–10 per 100,000 people per year [62], with a 6-month mortality rate ranging from 32 to 67%, and 30% of survivors harbor permanent neurological impairment [63].
In 20 to 40% of patients, new ischemic neurological decits that were not present on hospital admission become apparent in the days and weeks following the ictus and are mainly associated with vasospasm consequent to aSAH.Vasospasm usually occurs 3 to 14days following aneurysmal subarachnoid hemorrhage (aSAH), and it is known to be one of the causes leading to delayed cerebral ischemia (DCI) and poor outcomes [64].
Angiography is considered the gold standard for the detection of vasospasm; however, TCD has been extensively used for monitoring patients with aSAH, and it has been demonstrated to be able to assess vasospasm and monitor and guide the clinical treatment (triple-H therapy, angioplasty, etc.) [65].
TCD for the detection of vasospasm, usually performed on the MCA, has been studied by several authors. TCD is able to detect vasospasm as the constriction of the cerebral vessels leads to an increase of cerebral blood ow velocities [65].
According to a recent meta-analysis [66] including 2870 patients, TCD was found to be highly predictive of evidence of vasospasm in patients with aSAH with sensitivity of 90% (95% condence interval (CI) 77%–96%), specicity of 71% (95% CI 51%–84%), positive predictive value (PPV) of 57% (95% CI 38%–71%), and NPV of 92% (95% CI 83%–96%) at pooled estimates for TCD diagnosis of vasospasm.
Vora etal. [66] in a retrospective study of 101 patients found that MCA means ow velocity higher than 120cm/s had a specicity of 72% and sensitivity of 88% for 33% of angiographic vasospasm with a NPV of 94% for MFV< 120 cm/s. Moreover, MFV>200cm/s was 98% specic and 27% sensitive with a PPV of 87% for angiographic vasospasm of 33%.
11 Neurocritical Patient in ICU: Transcranial Doppler (TCD/TCCS) as the Brain…
207
To differentiate an increase of the CBFV related to systemic hyperdynamic ow and vasospasm, the Lindegaard ratio (LR) [67] is normally used, which is dened as MFV on the MCA divided for the extracranial ICA MFV.LR<3 indicates hyper­dynamic ow (hyperemia) and >3 indicates vasospasm. Mild vasospasm is dened as MFV > 120 and <149 cm/s (LR = 3–6); moderate vasospasm is dened as MFV > 150 and <199 (LR = 3–6) and severe vasospasm as MFV > 200 cm/s with LR>6.
TCD has been extensively used for the detection of cerebral vasospasm showing good sensitivity and specicity, but TCD can also have a role in the detection of cerebral autoregulation after aSAH.Late detection of impaired cerebral autoregula­tion in these patients [68] is associated with increased risk to develop DCI indepen­dently of the incidence of vasospasm [69], and it is associated with poorer outcome [70].
11.4.3 Stroke
In patients affected by internal carotid artery (ICA) stenosis, impaired autoregula­tion assessed by signicant increases in Mx and decreases in dynamic autoregula­tion index observed in the pathological stenoocclusive arteries have shown to correlate with the degree of stenosis and is considered a tool to identify patients at risk of stroke and for need of surgical decompression [71]. For instance, in a cohort of 48 patients with angiographic occlusion, TCD showed an overall sensitivity of 83% and specicity of 94%, especially in the anterior circulation [72].
TCD can also be a reliable prognostic indicator in MCA occlusive stroke [73], and its role in the assessment of cerebral autoregulation after stroke has been exten­sively studied. Some authors have consistently shown an impairment in ipsilateral cerebral autoregulation and an association with the need for decompressive surgery, neurological decline, and poor outcome [44].
TCD may also have a role in the prediction of outcome in patients with stroke, according to the site and severity of occlusion observed. In a study of 335 patients with acute stroke who received thrombolytic treatment, distal MCA occlusions assessed through TCD were associated with the greatest chance of early recanaliza­tion (44%), compared with 30% in the proximal MCA, 30% in the basilar artery, and <10% in the terminal ICA [74].
Despite the important role of TCD in patients with ischemic stroke, CTA and MRI are still considered rst-line imaging techniques due to the operator depen­dency and poor ability of TCD to access the posterior cerebral circulation [6].
208
C. Robba and D. Cardim
11.4.4 Other Clinical Scenarios
TCD presents a wide range of clinical applications in the context of anesthesiology, neurology, neurosurgery, and neurointensive care settings (Table11.2).
Besides the common previously described applications in neurointensive care settings (TBI, SAH, stroke), it has been successfully applied in the diagnosis of brainstem death [75] in central nervous system infections and in many ischemic cerebrovascular diseases (sickle cell disease, right to left cardiac shunt, venous thrombosis) in adult and pediatric populations [6, 76, 77].
Moreover, TCD is gaining interest even in the intraoperative settings. It has been successfully applied in order to assess nCPP and nICP in surgical procedures at risk of intracranial hypertension [78, 79], such as laparoscopic procedures with pneumo­peritoneum and Trendelenburg position [80]. It has been also successfully used for neuromonitoring during carotid endarterectomy or during cardiopulmonary bypass [81].
Growing and recent evidences support the use of TCD even in metabolic coma (such as during liver transplant or hepatic encephalopathy) or in pregnant patients to assess autoregulation and cerebrovascular changes as prognostic factor for pre­eclampsia and cerebrovascular events during pregnancy [82].
Finally, TCD has been recently applied in septic patients to assess nCPP and PI.Some authors found higher values of PI and cerebral vascular constriction in septic patients compared to control group, suggesting a possible role of TCD in the assessment of the mechanisms underlying the pathogenesis of sepsis-related encephalopathy [83].

11.5 Conclusion

The non-invasiveness, repeatability, portability, and high temporal resolution of TCD have promoted the wide use of this technique, especially for bedside monitor­ing of CBF in the neurocritical care settings.
Invasive techniques still appear to remain the gold standard across most of the clinical applications; moreover, operator dependency and the need for an appropri­ate temporal window are signicant limitations to TCD clinical utility.
However, despite some limitations including operator dependency and 10–20% of patients having inadequate transtemporal acoustic windows, TCD remains a valuable tool for the assessment of cerebral hemodynamics in critically ill patients. Its wide utility as a diagnostic tool makes it a useful “stethoscope for the brain.”
INTENSIVE CARE UNIT (ICU)
11 Neurocritical Patient in ICU: Transcranial Doppler (TCD/TCCS) as the Brain…

Algorithm

EMERGENCY DEPARTMENT (ED)
Clinical Status of Patient
ABCD Level of consciousness (Glasgow) Bilateral Pupillary reactivity Hemodynamic stability? Oxigenation?
DIAGNOSIS
Subarachnoid Hemorrhage (SAH) Ischemic Stroke Traumatic Brain Injury (TBI)
CNS infection (Meningitis/Encephalitis) Intracerebral Hemorrhage (ICH) Acute Liver Failure (ALF)
Brain Tumors Preeclampsia Neurosurgery Peri-operative
Brain Death Sickle Cell Disease Sepsis - Delirium
Cerebral Venous Thrombosis Right to Left cardiac shunt
Multimodal Monitoring (MMM)
Transcranial Color-Coded duplex Sonography (TCCS)
Transcranial Doppler (TCD)
209
Flow Velocity (FV) Pulasatility Index (PI) Autoregulation (AR) CrCP & Wall Tension (WT)
Spectral Waveform
Qualitatives – Quantitatives
Changes
(Trends)
PSV / MFV / EDV Spectral Waveform Changes? Zero or negative value
Cerebral arterial Compliance (Ca) Cerebrovascular Time Non-invasive ICP/ CPP
Compliance of Intracranial space (Ci)
Cerebral Compliance
CaABP CaBV
Ci
BASIC SIGNALS ADVANCED SIGNALS
ICP
PI: (PSV – EDV) / MFV
0.5 – 1.1
Cerebral vascular resistance
TCD/TCCS – based index
CaBV
TAU = Ca x CVR (sec.)
Constant (TAU) (nICP) / (nCPP)
Time Changes
Dynamic AR
Indexes Measurement
MFV & CPP (Mx) PSV & CPP (Sx)
(AR is preserved)
Positive value
(Impaired AR)
Pressure (mmHg)
Measurements
CrCP (mmHg)
DCM (mmHg)
ESTIMATE
ICP
CPP
Pressure (mmHg)
nICP = ABP - nCPP
ABCD Airway-breathing-circulation-disability, CPP Cerebral Perfusion Pressure, ICP Intracranial Pressure/MFV Mean ow velocity, EDV diastolic ow Velocity, PSV Peak systolic ow velocity, Ca Cerebral arterial compliance, Ci Compliance of intracranial space, CVR Cerebrovascular resistance

References

1. White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive
Care Med. 2006;32:981–94.
2. Trabold F, Meyer PG, Blanot S, Carli PA, Orliaguet GA.The prognostic value of transcra-
nial Doppler studies in children with moderate and severe head injury. Intensive Care Med. 2004;30(1):108–12.
3. Hoffmann O, Zierski JT.Analysis of the ICP pulse-pressure relationship as a function of arterial
blood pressure: clinical validation of a mathematical model. Acta Neurochir. 1982;66:1–21.
210
4. Bekker A, Wolk S, Turndorf H, Kristol D, Ritter A.Computer simulation of cerebrovascular
circulation: assessment of intrac rani al hemodynamics during induction of anesthesia. J Clin Monit. 1996;12(6):433–44.
5. De Riva N, Budohoski KP, Smielewski P, Kasprowicz M, Zweifel C, Steiner LA, et al.
Transcranial doppler pulsatility index: what it is and what it isn’t. Neurocrit Care. 2012;17(1):58–66.
6. Naqvi J, Yap KH, Ahmad G, Ghosh J.Review article transcranial Doppler ultrasound: a review
of the physical principles and major applications in critical care. 2013;2013(March).
7. Nicoletto HA, Burkman MH. Transcranial Doppler series part III: interpretation. Am J
Electroneurodiagnostic Technol [Internet]. 2009 Sep [cited 2017 Aug 25];49(3):244–59.
8. Nicoletto HA, Burkman MH. Transcranial Doppler series part IV: case studies. Am J
Electroneurodiagnostic Technol [Internet]. 2009 Dec [cited 2017 Aug 25];49(4):342–60.
9. Tegeler CH, Crutcheld K, Katsnelson M, Kim J, Tang R, Passmore Grifn L, etal. Transcranial
doppler velocities in a large, healthy population. J Neuroimaging. 2013;23(3):466–72.
10. Giller CA, Hodges K, Batjer HH.Transcranial Doppler pulsatility in vasodilation and stenosis.
J Neurosurg. 1990;72:901–6.
11. Czosnyka M, Richards HK, Whitehouse HE, Pickard JD.Relationship between transcranial
Doppler-determined pulsatility index and cerebrovascular resistance: an experimental study. J Neurosurg. 1996;84(1):79–84.
12. Cardim D, Robba C, Bohdanowicz M, Donnelly J, Cabella B, Liu X, et al. Non-invasive
monitoring of intracranial pressure using transcranial Doppler ultrasonography: is it possible? Neurocrit Care [Internet]. 2016 [cited 2016 Mar 7].
13. Czosnyka M, Smielewski P, Piechnik S, Schmidt EA, Al-Rawi PG, Kirkpatrick PJ, et al.
Hemodynamic characterization of intracranial pressure plateau waves in head-injured patients. J Neurosurg. 1999;91(1):11–9.
14. Avezaat C, Van Eijndhoven J.Cerebrospinal uid pulse pressure and craniospinal dynamics: a
theoretical, clinical and experimental study. Resuscitation. 1984:111–26.
15. Cardim D, Schmidt B, Robba C, Donnelly J, Puppo C, Czosnyka M, et al. Transcranial
Doppler monitoring of intracranial pressure plateau waves. Neurocrit Care [Internet]. Springer US; 2016 Dec 20 [cited 2017 May 15];1–9.
16. Oktar SO, Yücel C, Karaosmanoglu D, Akkan K, Ozdemir H, Tokgoz N, etal. Blood-ow
volume quantication in internal carotid and vertebral arteries: comparison of 3 different ultra­sound techniques with phase-contrast MR imaging. Am J Neuroradiol. 2006;27(2):363–9.
17. Rosner MJ, Becker DP.Origin and evolution of plateau waves. Experimental observations and
a theoretical model. J Neurosurg. 1984;60(2):312–24.
18. Kim DJ, Kasprowicz M, Carrera E, Castellani G, Zweifel C, Lavinio A, etal. The moni-
toring of relative changes in compartmental compliances of brain. Physiol Meas [Internet]. 2009;30(7):647–59.
19. Eide PK, Sorteberg A, Bentsen G, Marthinsen PB, Stubhaug A, Sorteberg W.Pressure-derived
versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in rela­tion to early clinical state and 12-month outcome following aneurysmal subarachnoid hemor­rhage. J Neurosurg. 2012;116(5):961–71.
20. Czosnyka M, Richards HK, Reinhard M, Steiner LA, Budohoski K, Smielewski P, et al.
Cerebrovascular time constant: dependence on cerebral perfusion pressure and end-tidal car­bon dioxide concentration. Neurol Res. 2012;34(1):17–24.
21. Kasprowicz M, Diedler J, Reinhard M, Carrera E, Smielewski P, Budohoski KP, etal. Time
constant of the cerebral arterial bed. Acta Neurochir Suppl [Internet]. 2012 Jan [cited 2016 Mar 24];114:17–21.
22. Kasprowicz M, Czosnyka M, Soehle M, Smielewski P, Kirkpatrick PJ, Pickard JD, et al.
Vasospasm shortens cerebral arterial time constant. Neurocrit Care. 2012;16(2):213–8.
23. Tromov A, Kalentiev G, Gribkov A, Voennov O, Grigoryeva V. Cerebrovascular time con-
stant in patients with head injury. Acta Neurochir Suppl. 2016;121:295–7.
C. Robba and D. Cardim
11 Neurocritical Patient in ICU: Transcranial Doppler (TCD/TCCS) as the Brain…
24. Nichol J, Girling F, Jerrard W, Claxton EB, Burton AC.Fundamental instability of the small
blood vessels and critical closing pressures in vascular beds. Am J Physiol [Internet]. 1951 Feb [cited 2015 Aug 4];164(2):330–44.
25. Michel E, Hillebrand S, von Twickel J, Zernikow B, Jorch G.Frequency dependence of cere-
brovascular impedance in preterm neonates: a different view on critical closing pressure. J Cereb Blood Flow Metab. 1997;17(10):1127–31.
26. Varsos GV, Richards H, Kasprowicz M, Budohoski KP, Brady KM, Reinhard M, etal. Critical
closing pressure determined with a model of cerebrovascular impedance. J Cereb Blood Flow Metab [Internet]. 2013;33(2):235–43.
27. Panerai RB. The critical closing pressure of the cerebral circulation. Med Eng Phys.
2003;25(8):621–32.
28. Czosnyka M, Smielewski P, Piechnik S, Al-Rawi PG, Kirkpatrick PJ, Matta BF, etal. Critical
closing pressure in cerebrovascular circulation. J Neurol Neurosurg Psychiatry [Internet]. 1999;66(5):606–11.
29. Aaslid R, Lash SR, Bardy GH, Gild WH, Newell DW.Dynamic pressure–ow velocity rela-
tionships in the human cerebral circulation. Stroke. 2003;34(7):1645.
30. Aaslid R, Lash SR, Bardy GH, Gild WH, Newell DW.Dynamic pressure-ow velocity rela-
tionships in the human cerebral circulation. Stroke. 2003;34(7):1645–9.
31. Puppo C, Camacho J, Yelicich B, Moraes L, Biestro A, Gomez H.Bedside study of cerebral
critical closing pressure in patients with severe traumatic brain injury: a transcranial Doppler study. Acta Neurochir Suppl. 2012;114:283–8.
32. Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ.Critical closing pressure in subarachnoid
hemorrhage: effect of cerebral vasospasm and limitations of a transcranial Doppler-derived estimation. Stroke. 2004;35(6):1393–8.
33. Varsos GV, Richards HK, Kasprowicz M, Reinhard M, Smielewski P, Brady KM, et al.
Cessation of diastolic cerebral blood ow velocity: the role of critical closing pressure. Neurocrit Care. 2014;20(1):40–8.
34. Donnelly J, Czosnyka M, Harland S, Varsos GV, Cardim D, Robba C, etal. Cerebral haemody-
namics during experimental intracranial hypertension. J Cereb Blood Flow Metab [Internet]. 2017;37(2):694–705.
35. Czosnyka M, Smielewski P, Piechnik S, Pickard JD.Clinical signicance of cerebral autoregu-
lation. Acta Neurochir Suppl. 2002;81:117–9.
36. Bouma GJ, Muizelaar JP, Bandoh K, Marmarou A.Blood pressure and intracranial pressure-
volume dynamics in severe head injury: relationship with cerebral blood ow. J Neurosurg. 1992;77(1):15–9.
37. Zweifel C, Lavinio A, Steiner LA, Radolovich D, Smielewski P, Timofeev I, etal. Continuous
monitoring of cerebrovascular pressure reactivity in patients with head injury. Neurosurg Focus. 2008;25(4):E2.
38. Panerai RB.Transcranial Doppler for evaluation of cerebral autoregulation. Clin Auton Res.
2009;19(4):197–211.
39. Tiecks FP, Lam AM, Aaslid R, Newell DW.Comparison of static and dynamic cerebral auto-
regulation measurements. Stroke. 1995;26(6):1014–9.
40. Donnelly J, Aries MJ, Czosnyka M.Further understanding of cerebral autoregulation at the
bedside: possible implications for future therapy. Expert Rev Neurother. 2015;15(2):169–85.
41. Zhang R, Zuckerman JH, Giller CA, Levine BD.Transfer function analysis of dynamic cere-
bral autoregulation in humans. Am J Phys. 1998;274:233–41.
42. Czosnyka M, Smielewski P, Kirkpatrick P, Menon DK, Pickard JD. Monitoring of cerebral
autoregulation in head-injured patients. Stroke. 1996;27:1829–34.
43. Budohoski KP, Reinhard M, Aries MJH, Czosnyka Z, Smielewski P, Pickard JD, et al.
Monitoring cerebral autoregulation after head injury. Which component of transcranial Doppler ow velocity is optimal? Neurocrit Care. 2012;17(2):211–8.
44. Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ.Cerebral autoregulation in
stroke: a review of transcranial doppler studies. Stroke. 2010;41:2697–704.
211
212
45. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al.
Guidelines for the management of severe traumatic brain injury. IX.Cerebral perfusion thresh­olds. J Neurotrauma. 2007;24 Suppl 1:S59–64.
46. Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg HM, etal. Ventriculostomy
infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85(3):419–24.
47. Bellner J, Romner B, Reinstrup P, Kristiansson KA, Ryding E, Brandt L. Transcranial
Doppler sonography pulsatility index (PI) reects intracranial pressure (ICP). Surg Neurol. 2004;62:45–51.
48. Zweifel C, Czosnyka M, Carrera E, de Riva N, Pickard JD, Smielewski P.Reliability of
the blood ow velocity pulsatility index for assessment of intracranial and cerebral perfu­sion pressures in head-injured patients. Neurosurgery [Internet]. 2012 Oct [cited 2015 Jul 21];71(4):853–61.
49. Kashif FM, Verghese GC, Novak V, Czosnyka M, Heldt T.Model-based noninvasive estima-
tion of intracranial pressure from cerebral blood ow velocity and arterial pressure. Sci Transl Med. 2012;4(129):129ra44.
50. Aaslid R, Lundar T, Lindegaard KF, etal. No title. In: Miller JD, Teasdale GM, Rowan JO,
editors. Intracrani. Berlin: Springer- Verlag; 1986. p.226–32.
51. Czosnyka M, Matta BF, Smielewski P, Kirkpatrick PJ, Pickard JD.Cerebral perfusion pressure
in head-injured patients: a noninvasive assessment using transcranial Doppler ultrasonogra­phy. J Neurosurg. 1998;88:802–8.
52. Varsos G V, Kolias AG, Smielewski P, Brady KM, Varsos VG, Hutchinson PJ, etal. A nonin-
vasive estimation of cerebral perfusion pressure using critical closing pressure. J Neurosurg. 2015;11.
53. Cardim D, Schmidt B, Robba C, Donnelly J, Puppo C, Czosnyka M, et al. Transcranial
Doppler monitoring of intracranial pressure plateau waves. Neurocrit Care [Internet]. Springer US; 2016 Dec 20 [cited 2017 Feb 15];1–9.
54. Koskinen LOD, Olivecrona M. Clinical experience with the intraparenchymal intracranial
pressure monitoring Codman microsensor system. Neurosurgery. 2005;56(4):693–7.
55. Eide PK, Park E-H, Madsen JR.Arterial blood pressure vs intracranial pressure in normal pres-
sure hydrocephalus. Acta Neurol Scand [Internet]. 2010 [cited 2012 Mar 11];122(4):262–9.
56. Zacchetti L, Magnoni S, Di Corte F, Zanier ER, Stocchetti N.Accuracy of intracranial pressure
monitoring: systematic review and meta-analysis. Crit Care [Internet]. 2015;19(1):420.
57. Czosnyka M, Smielewski P, Timofeev I, Lavinio A, Guazzo E, Hutchinson P, etal. Intracranial
pressure: more than a number. Neurosurg Focus. 2007;22(5):E10.
58. Lane PL, Skoretz TG, Doig G, Girotti MJ.Intracranial pressure monitoring and outcomes after
traumatic brain injury. Can J Surg. 2000;43(6):442–8.
59. Muttaqin Z, Uozumi T, Kuwabara S, Arita K, Kurisu K, Ohba S, etal. Hyperaemia prior to
acute cerebral swelling in severe head injuries: the role of transcranial Doppler monitoring. Acta Neurochir. 1993;123(1–2):76–81.
60. Bouzat P, Oddo M, Payen J-F.Transcranial Doppler after traumatic brain injury: is there a
role? Curr Opin Crit Care. 2014;20(2):153–60.
61. Bouzat P, Almeras L, Manhes P, Sanders L, Levrat A, David J-S, etal. Transcranial Doppler
to predict neurologic outcome after mild to moderate traumatic brain injury. Anesthesiology. 2016;PublishedA(May).
62. Rincon F, Rossenwasser RH, Dumont A.The epidemiology of admissions of nontraumatic
subarachnoid hemorrhage in the United States. Neurosurgery. 2013;73(2):217–22.
63. Hop JW, Rinkel GJE, Algra A, van Gijn J.Case-fatality rates and functional outcome after
subarachnoid hemorrhage: a systematic review. Stroke. 1997;28(3):660–4.
64. Diringer MN, Bleck TP, Hemphill JC, Menon D, Shutter L, Vespa P, etal. Critical care man-
agement of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211–40.
C. Robba and D. Cardim